ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Overview Fund Activity
Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

38 hedge funds and large institutions have $4.58M invested in Oncternal Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-12
Holders Change %
-24%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
8
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Millennium Management
Millennium Management
New York
$1.1M
2
PPW
Pasadena Private Wealth
California
$268K
3
Morgan Stanley
Morgan Stanley
New York
$99.7K
4
Citadel Advisors
Citadel Advisors
Florida
$29.1K
5
TSS
Two Sigma Securities
New York
$31.5K

Top Sellers

1
Geode Capital Management
Geode Capital Management
Massachusetts
$0
2
QPW
Quantum Private Wealth
Florida
$0
3
BJL
Brighton Jones LLC
Washington
$0
4
Corient Private Wealth
Corient Private Wealth
Florida
$0
5
Envestnet Asset Management
Envestnet Asset Management
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of New York Mellon
51
Bank of New York Mellon
New York
– -$5.28K -880 Closed
Jane Street
52
Jane Street
New York
– -$3.09K -514 Closed
BBA
53
Baader Bank Aktiengesellschaft
Germany
– -$2.71K -507 Closed
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
– -$3K -500 Closed
NRG
55
Nemes Rush Group
Michigan
– -$22 -4 Closed
1 2
3